Lindt & Sprüngli completes buyback program ahead of schedule, launches new CHF 1 billion buyback starting in May 2026 ...
Bossard Holding AG / Key word (s): Quarter Results Sales for the first quarter 2026 10-Apr-2026 / 06:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely ...
VAT Group AG invites to first quarter 2026 trading update conference call with CEO and CFO reporting on business conditions and expectations for 2026. Q&A session included ...
Compagnie Chargeurs Invest announces Combined Shareholders' General Meeting on April 30, 2026. Proxy documents available online. Company details and financial calendar included ...
Komax Holding AG shareholders approve all proposals at the Annual General Meeting, re-elect Board members and express gratitude for outgoing members and CEO. Measures taken to reduce costs highlighted ...
A/S announced resolutions of its 2026 annual general meeting, including approval of the Annual Report for 2025 and elections of board members. No dividend for 2025 ...
ROK Resources Inc. announces 2026 Budget focusing on development and reserve growth. Operational highlights include debt reduction, increased production, and hedge gains. Details on drilling, ...
BlackBerry Limited reports strong financial performance with 10% year-over-year revenue growth and eighth consecutive quarter improvement in GAAP net income, consolidating its position as a growth com ...
MPC Capital invites to FY 2025 earnings webcast on 9 April 2026. CEO and CFO to present financial figures, business update, and 2026 outlook ...
Maisons du Monde continues negotiations with financial partners and seeks strategic backing to secure financing. Intense discussions ongoing amidst challenging environment ...
ABB Ltd repurchased 263,000 shares from April 2, 2026, to April 8, 2026, as part of their buyback program. Transactions executed on SIX Swiss Exchange by a bank ...
Inventiva files 2025 Universal Registration Document and Annual Report on Form 20-F with AMF and SEC, focusing on MASH therapies ...